ATTRALUS

Dead / Abandoned — Abandoned — failure to respond (as of 30 Jul 2024)

What this means for you

This application is over — abandoned 16 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90104221
Mark type
Stylized text
Filed
10 Aug 2020
Published for opposition
12 Jan 2021
Abandoned
16 Jul 2024
Attorney of record
Dusan Clark

Goods and services

  • Class 005 — Pharmaceuticals: Diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical purposes, namely, diagnostic scanning agents for in vivo use for detection and monitoring of systemic amyloid diseases, such as transthyretin amyloidosis, Light Chain Amyloidosis and LECT2 Amyloidosis; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the field of systemic amyloid disease; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis and treatment of systemic amyloid disease; all of the aforesaid for human use

Owner

Prosecution history

  • 30 Jul 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
  • 30 Jul 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
  • 15 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 15 Apr 2024 — NON-FINAL ACTION E-MAILED
  • 15 Apr 2024 — SU - NON-FINAL ACTION - WRITTEN
  • 11 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
  • 08 Mar 2024 — USE AMENDMENT FILED
  • 08 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
  • 15 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 14 Sept 2023 — SOU EXTENSION 5 GRANTED
  • 17 Aug 2023 — SOU EXTENSION 5 FILED
  • 17 Aug 2023 — SOU TEAS EXTENSION RECEIVED
  • 03 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 01 Mar 2023 — SOU EXTENSION 4 GRANTED
  • 01 Mar 2023 — SOU EXTENSION 4 FILED

View this trademark record on Marksy